Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Prostatic Neoplasms × relugolix × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

enzalutamide 2 apalutamide 2 Pluvicto 2 Leuprolide 2 Androgen Antagonists 2 relugolix 1 luprolide acetate gel depot 1 gallium 68 PSMA-11 1 Prednisone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03085095 2022-01-18

HERO

Myovant Sciences GmbH

Phase 3 Completed

1,134 enrolled 38 charts 2 FDA

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡